RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEWC2F7E4F1DECD643F

https://w3id.org/ripe/ripe-kg/work/RIPEWC2F7E4F1DECD643F
SubjectPredicateObject
ripekg:work/10.1111%2F1756-185x.13688Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial http://purl.org/spar/cito/cites ripekg:work/RIPEWC2F7E4F1DECD643FCurcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways
ripekg:work/RIPEWC2F7E4F1DECD643FCurcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways dcterms:title Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways
ripekg:work/RIPEWC2F7E4F1DECD643FCurcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways rdf:type node1
ripekg:work/RIPEWC2F7E4F1DECD643FCurcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEWC2F7E4F1DECD643FCurcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways rdf:type rdfs:Resource
ripekg:work/RIPEWC2F7E4F1DECD643FCurcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways rdf:type owl:Thing
ripekg:work/RIPEWC2F7E4F1DECD643FCurcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways rdf:type prov:Entity
ripekg:work/RIPEWC2F7E4F1DECD643FCurcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways rdf:type ripe:WorkWork